{"id":"placebo-for-5-minoxidil-foam","safety":{"commonSideEffects":[{"rate":null,"effect":"Minimal expected adverse events (inert formulation)"}]},"_chembl":{"chemblId":"CHEMBL802","moleculeType":"Small molecule","molecularWeight":"209.25"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations are inert vehicles designed to match the appearance, texture, and administration method of the active drug being tested, allowing for blinded comparison in clinical trials. In this case, it mimics 5% minoxidil foam but contains no minoxidil or other active agents. Placebo controls help isolate the true therapeutic effect of minoxidil from psychological and environmental factors.","oneSentence":"This is a placebo control formulation with no active pharmaceutical ingredient, used as a comparator in clinical trials for minoxidil foam efficacy.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:54.607Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control for androgenetic alopecia (male pattern hair loss) trials"}]},"trialDetails":[{"nctId":"NCT07080931","phase":"PHASE3","title":"Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia","status":"RECRUITING","sponsor":"Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.","startDate":"2025-02-24","conditions":"Androgenetic Alopecia","enrollment":294},{"nctId":"NCT04721548","phase":"PHASE3","title":"Treatment of Androgenetic Alopecia in Men for 24 Weeks","status":"COMPLETED","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2023-03-02","conditions":"Alopecia","enrollment":336},{"nctId":"NCT03852992","phase":"PHASE2","title":"Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia","status":"WITHDRAWN","sponsor":"University of Minnesota","startDate":"2022-09-30","conditions":"Male Pattern Hair Loss, Androgenetic Alopecia, Male Pattern Baldness","enrollment":""},{"nctId":"NCT00151515","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2003-10","conditions":"Androgenetic Alopecia","enrollment":352},{"nctId":"NCT01226459","phase":"PHASE3","title":"Clinical Trial in Females for Female Pattern Hair Loss","status":"COMPLETED","sponsor":"Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.","startDate":"2010-09","conditions":"Androgenetic Alopecia","enrollment":404},{"nctId":"NCT01319370","phase":"PHASE2","title":"Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia","status":"COMPLETED","sponsor":"Natalie GARCIA BARTELS","startDate":"2010-11","conditions":"Androgenetic Alopecia","enrollment":70}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for 5% Minoxidil Foam","genericName":"Placebo for 5% Minoxidil Foam","companyName":"Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.","companyId":"zhejiang-sunshine-mandi-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control formulation with no active pharmaceutical ingredient, used as a comparator in clinical trials for minoxidil foam efficacy. Used for Placebo control for androgenetic alopecia (male pattern hair loss) trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}